Do coping styles mediate the relationship between substance use and educational attainment and antiretroviral adherence?

AIDS and Behavior

Volumn 16, Issue 8, 2012, Pages 2319-2329

  Martinez, David A ^a   Goggin, Kathy ^a   Catley, Delwyn ^a   Gerkovich, Mary M ^a   Williams, Karen ^a   Wright, Julie ^a   Berkley Patton, Jannette ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

ART adherence; Coping; Educational attainment; Substance use

Indexed keywords

ANTIRETROVIRUS AGENT;

ADAPTIVE BEHAVIOR; ADDICTION; ADULT; ARTICLE; BINGE DRINKING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RELIGION; SEXUALITY; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICAL MODEL; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTI-RETROVIRAL AGENTS; BINGE DRINKING; FEMALE; HIV INFECTIONS; HUMANS; KANSAS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RELIGION; SEXUALITY; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84868595580     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0222-1     Document Type: Article

References (63)

1. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997;337:734-9.
2. McMahon D, Lederman M, Haas DW, et al. Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naïve HIV-1 infected adults. Antivir Ther. 2001;6(2):105-14.
3. Saag MS, Tebas P, Sension M, et al. Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). AIDS. 2001;15(15): 1971-8.
4. Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. New Engl J Med. 1999;341(25):1865-73.
5. Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet. 1998;351(9102):543-9.
6. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337(11):725-33.
7. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet. 1998;352(9142):1725-30.
8. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13): 853-60.
9. DiIorio C, McCarty F, DePadilla L, et al. Adherence to antiretroviral medication regimens: a test of a psychosocial model. AIDS Behav. 2007;13(1):10-22.
10. Nischal KC, Khopkar U, Saple DG. Improving adherence to antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2005; 71(5):316-20.
11. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.
12. Johnson MO, Catz SL, Remien RH, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS. 2003;17(12):645-56.
13. Read T, Mijch A, Fairley CK. Adherence to antiretroviral therapy: are we doing enough? Intern Med J. 2003;33(5-6):254-6.
14. Altice FL, Friedland GH. The era of adherence to HIV therapy. Ann Intern Med. 1998;129(6):503-5.
15. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 2002;29(Suppl 1):S2-10.
16. Halkitis PN, Parsons JT, Wolitski RJ, Remien RH. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care. 2003;15(1):89-102.
17. Singh N, Squier C, Sivek C, Wagener M. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8(3):261-9.
18. Weidle PJ, Ganea CE, Irwin KL, et al. Adherence to antiretroviral medications in an inner-city population. J Acquir Immune Defic Syndr. 1999;22(5):498-502.
19. Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11(2):185-94.
20. Kim TW, Palepu A, Cheng DM, Libman H, Saitz R, Samet JH. Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems. AIDS Care. 2007;19(8):1039-47.
21. Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Guifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental problems. Health Psychol. 2004;23(4):363-70.
22. Ironson G, O'Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67(6):1013-21.
23. Marc LG, Testa MA, Walker AM, et al. Educational attainment and response to HAART during initial therapy for HIV-1 infection. J Psychosom Res. 2007;63(2):207-16.
24. Arnsten JH, Li X, Mizuno Y, Knowlton AR, Gourevitch MN, Handley K, Metsch LR. Factors associated with antiretroviral therapy adherence and medication errors in HIV-infected injection drug user. J Acquir Immune Defic Syndr. 2007;46(Suppl 2): S64-71.
25. Kennedy S, Goggin K, Nollen N. Adherence to HIV medications: utility of self-determination theory. Cognit Ther Res. 2004;28(5): 611-28.
26. Staiger PK, Melville F, Hides L, Kambouropoulos N, Lubman DI. Can emotion-focused coping help explain the link between posttraumatic stress disorder severity and triggers for substance use in young adults? J Subst Abuse Treat. 2009;36(2):220-6.
27. Ouimette PC, Finney JW, Moos RH. Two-year posttreatment functioning and coping of substance use patients with posttraumatic stress disorder. Psychol Addict Behav. 1999;33:105-14.
28. Balfour L, Kowal J, Silverman A, et al. A randomized controlled psycho-education intervention trial: improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART. AIDS Care. 2006;18(7):830-8.
29. Grassi L, Righi R, Sighinolfi L, Makoui S, Ghinelli F. Coping styles and psychosocial-related variables in HIV-infected patients. Psychosomatics. 1998;39(4):350-9.
30. Hobfoll SE, Schröder KE. Distinguishing between passive and active prosocial coping: bridging inner-city women's mental health and AIDS risk behavior. J Soc Pers Relat. 2001;18(2): 201-17.
31. Jacobson CJ, Luckhaupt SE, Delaney S, Tsevat J. Religio-biography, coping, and meaning-making among persons with HIV/AIDS. J Sci Study Relig. 2006;45(1):39-56.
32. Vosvick M, Koopman C, Gore-Felton C, Thoresen C, Krumboltz J, Spiegel D. Relationship of functional quality of life to strategies for coping with the stress of living with HIV/AIDS. Psychosomatics. 2003;44(1):51-8.
33. Gore-Felton C, Koopman C. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosom Med. 2008;70(5):569-74.
34. Ironson G, Friedman A, Klimas N, et al. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med. 1994;1(1):90-105.
35. Richardson A, Ander N, Nordstrom G. Persons with insulindependent diabetes mellitus: acceptance and coping ability. J Adv Nurs. 2001;33(6):758-63.
36. Chao HL, Tsai TY, Livneh H, Lee HC, Hsieh PC. Patients with colorectal cancer: relationships between demographic and disease characteristics and acceptance of disability. J Adv Nurs. 2010; 66(10):2278-86.
37. Janowski K, Steuden S, Kurylowicz J. Factors accounting for psychosocial functioning in patients with low back pain. Eur Spine J. 2010;19(4):613-23.
38. Li L, Moore D. Acceptance of disability and its correlates. J Soc Psych. 1998;138(1):13-25.
39. Woodrich F, Patterson JB. Variables related to acceptance of disability in persons with spinal cord injuries. J Rehabil. 1983; 49(3):26-30.
40. Aspinwall LG, Taylor SE. Modeling cognitive adaptation: a longitudinal investigation of the impact of individual differences and coping on college adjustment and performance. J Pers Soc Psychol. 1992;63(6):989-1003.
41. Billings AG, Moos RH. The role of coping responses and social resources in attenuating the stress of life events. J Behav Med. 1981;4(2):139-57.
42. Fleishman JA, Fogel B. Coping and depressive symptoms among people with AIDS. Health Psychol. 1994;13(2):156-69.
43. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.
44. Weaver KE, Llabre MM, Durán RE, et al. A stress and coping model of adherence and viral load in HIV-positive men and women in highly active antiretroviral therapy (HAART). Health Psychol. 2005;24(4):385-92.
45. Bader A, Kremer H, Erlich-Trungenberger I, et al. An adherence typology: coping, quality of life, and physical symptoms of people with HIV/AIDS and their adherence to antiretroviral treatment. Med Sci Monit. 2006;12(12):CR493-500.
46. Cotton S, Puchalski CM, Sherman SN, et al. Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med. 2006; 21(Suppl 5):S5-13.
47. Pargament, KI. Religious/spiritual coping. Multidimensional measurement of religiousness/spirituality for use in health research. A Report of the Fetzer Institute/National Institute on Aging Working Group, Kalamazoo; 1999.
48. Goggin K, Gerkovich M, Williams K, et al. Outcomes of project MOTIV8: a RCT of novel behavioral interventions for ART adherence. In: Presented at the proceedings of NIMH/IAPAC international conference on HIV treatment, Miami, May 23-25, 2010 (abstract no. 62097).
49. Grant KA, Tonigan JS, Miller WR. Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol. 1995;56(2):168-72.
50. Carver CS. You want to measure coping but your protocol's too long: consider the Brief COPE. Int J Behav Med. 1997;4(1): 92-100.
51. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7(1):83-104.
52. Kline RB. Principles and practice of structural equation modeling. New York: The Guilford Press; 2005.
53. Ickovics JR, Forsyth B, Ethier KA, Harris P, Rodin J. Delayed entry into health care for women with HIV: implications of time of diagnosis for early medical intervention. AIDS Patient Care STDS. 1996;10(1):21-4.
54. Miller NS, Ninonuevo FG, Klamen DL, Hoffman NG, Smith DE. Integration of treatment and posttreatment variables in predicting results of abstinence-based outpatient treatment after one year. J Psychoactive Drugs. 1997;29(3):239-48.
55. Moyers TB, Martin T, Houck JM, Christopher PJ, Tonigan JS. From in-session behaviors to drinking outcomes: a casual chain for motivational interviewing. J Consult Clin Psychol. 2009; 77(6):1113-24.
56. Koenig L, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159-69.
57. Finocchario-Kessler S, Catley D, Berkley-Patton J, et al. Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs. AIDS Patient Care STDS. 2011; 25(2):103-11.
58. Monti PM, Rohsnow DJ. Coping-skills training and cue-exposure therapy in the treatment of alcoholism. Alcohol Res Health. 1999;23(2):107-15.
59. Chang EC, Downey CA, Salata JL. Social problem solving and positive psychological functioning: looking at the positive side of problem solving. In: Chang EC, D'Zurilla TJ, Sanna LJ, editors. Social problem solving: theory, research, and training. Washington: American Psychological Association; 2004.
60. Henrich TJ, Lauder N, Desai MM, Sofair AN. Association of alcohol and injection drug use with immunologic and virologic responses to HAART with HIV-positive patients from urban community health clinics. J Commun Health. 2008;33(2):69-77.
61. Cook BL, Alegria M. Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status. Psychiatr Serv. 2011;62(11):1273-81.
62. Turner WL, Wallace B. African American substance use: epidemiology, prevention, and treatment. Violence Against Women. 2003;9(5):576-89.
63. Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIV-positive women with depression in rural areas of the southeastern United States. AIDS Patient Care STDS. 2007;21(9):667-80.